UK trial

A trial is being conducted in the UK using aspirin as part of treatment for triple negative breast cancer. The article emphasises the trial and methodology is still at an early stage and people should NOT start using aspirin themselves! 

Trial lead Dr Anne Armstrong said: "Not all breast cancers respond well to immunotherapy. 

"Trialling the use of a drug like aspirin is exciting because it is so widely available and inexpensive to produce. 

"We hope our trial will show that, when combined with immunotherapy, aspirin can enhance its effects and may ultimately provide a safe new way to treat breast cancer."

Co-researcher Dr Rebecca Lee said their lab findings suggested that aspirin can make certain types of immunotherapy more effective by preventing the cancer from making substances that weaken the immune response. 

"We hope aspirin can dampen down bad inflammation so the immune system can get on with the job of killing cancer cells," she said.